-
Electronic (PDF)
-
Site License
-
Enterprisewide
OraSure Technologies, Inc. (OSUR) - Financial and Strategic SWOT Analysis Review
GlobalData, August 2011, Pages: 51
OraSure Technologies, Inc. (OSUR) - Financial and Strategic SWOT Analysis Review
Summary
OraSure Technologies, Inc. (OraSure) principally operates in the in vitro diagnostics segment. The company is engaged in the development, manufacture and sale of oral fluid specimen collection devices, diagnostic products, and other medical devices. The company also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications. Its products are distributed in the US and international market through various hospitals, clinics, community-based organizations and other public health organizations, distributors, government clinical laboratories, government agencies, physicians’ offices, and commercial and industrial entities. OraSure is headquartered in Pennsylvania, the US.
This comprehensive SWOT profile of OraSure Technologies, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
OraSure Technologies, Inc. - Key Facts
OraSure Technologies, Inc. - Key Employees
OraSure Technologies, Inc. - Key Employee Biographies
OraSure Technologies, Inc. - Major Products and Services
OraSure Technologies, Inc. - Medical Equipment Pipeline Products Data
OraSure Technologies, Inc. Pipeline Products by Equipment Type
OraSure Technologies, Inc. Pipeline Products by Development Stage
OraSure Technologies, Inc. - History
OraSure Technologies, Inc. - Company Statement
OraSure Technologies, Inc. - Locations And Subsidiaries
Head Office
OraSure Technologies, Inc. - Key Manufacturing Facilities
Section 2 – Company Analysis
OraSure Technologies, Inc. - Business Description
OraSure Technologies, Inc. - Corporate Strategy
OraSure Technologies, Inc. - SWOT Analysis
SWOT Analysis - Overview
OraSure Technologies, Inc. - Strengths
Strength - Focused Research & Development Activities
Strength - Broad Product Portfolio
Strength - Good Resource Management
Weakness - High Dependency on the US Market
Weakness - Decline in Liquidity Reserves
Weakness - Low Debt to Equity Ratio
Opportunity - Collaboration with Roche Diagnostics
Opportunity - Growing In Vitro Diagnostics Market
Opportunity - Growth in Emerging Economies
Threat - Changes in Healthcare Regulations
Threat - Intense Competition
Threat - Industry Consolidation Challenges
OraSure Technologies, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
OraSure Technologies, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
OraSure Technologies, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
OraSure Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
OraSure Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
OraSure Technologies, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
May 04, 2011: OraSure Technologies Reports Revenues Of $17.4m In Q1 2011
Apr 07, 2011: OraSure Appoints Stephen Tang To Board Of Directors
Feb 09, 2011: OraSure Technologies Reports Revenues Of $75.01m In 2010
Jan 04, 2011: OraSure Appoints Tony Zezzo As New Executive Vice President, Marketing And Sales
Nov 09, 2010: OraSure Reports Net Revenues Of $19.03 Million For Q3 2010
Aug 19, 2010: Amerinet Partners With St. Barnabas-Bronx And OraSure Technologies To Implement Efficient HIV Testing Procedures
Aug 04, 2010: OraSure Reports Net Loss Of $0.5 Million For Q2 2010
May 13, 2010: OraSure Technologies Eliminates 18 Positions At Its Bethlehem Plants
May 05, 2010: OraSure Technologies Reports Revenues Of $17.9 Million In Q1 2010
Feb 10, 2010: OraSure Technologies Reports Revenues Of $77 Million In 2009
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Johnson & Johnson
Abbott Laboratories
Maxim Biomedical, Inc.
Trinity Biotech Plc
MedMira Inc.
Chembio Diagnostic, Inc.
Alere Inc.
F. Hoffmann-La Roche Ltd.
Psychemedics Corporation
Bio-Rad Laboratories, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
